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Abstract
Background: Coronary flow reserve (CFR) is used as a measure of coronary endothelial function. We investigated the effect
of increased afterload on CFR of pregnant and non-pregnant rats.
Methods: Afterload increase in Wister rats (both pregnant and non-pregnant) was achieved by the infusion of angiotensin II
(Ang II) for ,10 days or by subjecting them to transverse aortic constriction (TAC) for ,14 days. Control groups were
infused with 0.9% NaCl or had sham surgery, respectively. In pregnant rats, the experiments were performed close to term
gestation. Doppler velocity waveforms of the left main coronary artery were recorded using a high resolution ultrasound
imaging system (Vevo 770, VisualSonics, Canada) at baseline while the animals were anesthetized with 1.5% inhaled
isoflurane, and during maximal coronary dilatation obtained by the inhalation of 3.5% of isoflurane. CFR was calculated as
the ratio between the peak coronary flow velocities (CFRpeak) and the velocity-time integrals (CFRVTI) recorded at hyperemia
and at baseline.
Results: CFR could be calculated in 60 of 75 (80%) animals. There were no differences in CFR between intervention and
control groups irrespective of whether afterload was increased by Ang II or TAC. In the TAC-study CFRpeak (1.5460.07 vs
1.8560.17; p = 0.03) was decreased in pregnant compared to non-pregnant shams. When sham animals from both studies
were pooled together both CFRpeak (1.4260.07 vs 1.8660.16; p = 0.005) as well as CFRVTI (1.4560.07 vs 1.7860.12; p = 0.03)
were significantly lower in pregnant rats compared to non-pregnant.
Conclusions: CFR can be measured non-invasively in rats using Doppler echocardiography and high concentrations of
inhaled isoflurane as a coronary vasodilator. In pregnant rats, CFR is reduced close to term. CFR is not affected by increased
left ventricular afterload caused by chronic Ang II infusion or TAC.
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Introduction
Coronary flow reserve (CFR), i.e. the ratio of maximum to
baseline coronary blood flow [1], is used as a measure of coronary
endothelial function. Human studies have shown a link between
impaired coronary microvascular function and adverse cardiovas-
cular events [2,3]. In order to measure CFR, application of an
agent with potent endothelium independent vasodilating proper-
ties is needed. Adenosine administered intravenously is usually
preferred due to its rapid action and short half time [1,4], and has
been used in both human [5,6] and animal studies [7,8]. Inhaled
isoflurane, which is used as an anaesthetic in small animal
research, is a potent coronary vasodilator. Hartley et al. have
shown that the increase in coronary blood flow after administering
high concentrations of inhaled isoflurane can be used to estimate
CFR in mice [9,10].
Normal pregnancy is characterised by increased cardiac preload
and decreased afterload [11,12]. However, in hypertensive
disorders of pregnancy, and in some women with congenital
heart defects, the heart may be exposed to pathologically increased
afterload [13]. Increased afterload reduces CFR in humans with
aortic stenosis [14], and in dogs [15] and mice [10] with cardiac
hypertrophy following aortic banding. Endothelium-dependent
vasodilatation can be examined non-invasively in humans
measuring flow mediated dilatation (FMD) of the brachial artery
[16,17], and several studies have evaluated FMD in pregnancy
[18–24]. However, it is debated whether endothelial function in
the peripheral vessels correlates with endothelial function in the
coronary vascular bed [1,17,25,26]. Furthermore, we are not
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aware of any published studies evaluating endothelial function in
the coronary circulation during pregnancy, and to our knowledge
the effect of increased afterload on CFR during pregnancy has not
been reported.
The aims of this study were to (1) evaluate a non-invasive
method of assessing CFR in rats using different concentrations of
inhaled isoflurane for coronary vasodilation, (2) to investigate the
differences in CFR between pregnant and non-pregnant rats and




Animal experiments conformed to the Directive 2010/63/EU
of the European Parliament on the protection of animals used for
scientific purposes [27] and all procedures were approved by the
Norwegian Committee on Ethics in Animal Experimentation
(project ID 907 and 2177).
CFR was measured in young, female Wistar rats (Charles River,
Sulzfeld, Germany) included in two experimental studies of
increased cardiac afterload in pregnancy [28,29]. In the first
study (Ang II-study) mini osmotic pumps (Alzet Model 2002,
Cupertino, CA, USA) releasing 150 ng/kg/min of angiotensin
(Ang) II (Calbiochem, Darmstadt, Germany) or 0.9% sodium
chloride was implanted subcutaneously in the neck of pregnant
and non-pregnant rats for ,10 days [28]. In the second study
(TAC-study) transverse aorta constriction (TAC) or sham surgery
was performed ,14 days before the experiments in pregnant (on
gestational day 5–8) and non-pregnant rats [29]. Both interven-
tions led to increased afterload and cardiac hypertrophy with
increased mean pressure in ascending aorta (AngII-study:
11065 mmHg vs 8465 mmHg, p = 0.001. TAC-study:
12763 mmHg vs 9665 mmHg, p,0.001) and heart weight
(AngII-study: 896630 mg vs 768615 mg, p = 0.001. TAC-study:
845629 mg vs 671614 mg, p,0.001) as well as increased
expression of B-type natriuretic peptide [28,29]. In both studies
the pregnant rats were examined close to term gestation
(term = ,21 days). Ten male rats were used to practice and
evaluate the experimental procedure, dose of inhaled isoflurane
and timing of CFR measurement using Doppler echocardiogra-
phy. In four non-pregnant rats we compared the effect of 140 mg/
kg/min continuous adenosine [8] infusion through the external
jugular vein to 3.5% isoflurane inhalation.
Echocardiography was performed using a high resolution
ultrasound imaging system equipped with a RMV-710B trans-
ducer with a frequency of 25 MHz and a fixed focal length of
15 mm mounted on an integrated rail system (Vevo 770,
Visualsonics, Toronto, Canada) as described earlier [28,29].
Anesthesia was induced with isoflurane 4% in 100% oxygen in
an induction chamber. The rats were placed supine on a warm
electric pad and inhaled isoflurane 1.5% in 100% oxygen was
provided via a mask covering the rat’s snout (Vevo Compact
Anesthesia System, VisualSonics, Toronto, Canada) in spontane-
ously breathing rats (Ang II-study) or via an endotracheal tube in
ventilated rats (TAC-study). The Doppler signals from the left
main coronary artery (LMCA) was obtained from the parasternal
short-axis view (Fig. 1A) by visualizing the aortic root and then
moving the Doppler gate slightly anterior and to the left of the
aorta. Doppler velocity waveforms with the highest peak flow
velocity were recorded (Fig. 1B). Doppler signals could be detected
even when the LMAC was not clearly visualized in B-mode
echocardiography. After performing baseline measurements, the
isoflurane concentration was increased to 3.5% and another
recording of the LMCA Doppler signals was obtained after
2 minutes with the ultrasound probe fixed in the same position
(Fig. 1C).
Echocardiography was performed without the knowledge of
intervention, but the operator could not be blinded for pregnancy
status. All ultrasound measurements were performed off-line
without the knowledge of the animals’ pregnancy status and
intervention. Three consecutive cycles with good quality signals
were measured and the average value was used for the statistics.
Velocity-time integral (VTI) was outlined manually using the
software provided with the ultrasound equipment (VisualSonics
Vevo 770 v.3.0.0, Fig. 1BC), and peak velocity and VTI were
Figure 1. Measurement of coronary flow using Doppler echocardiography in rats. Parasternal short axis view of the heart (A) showing the
Aorta (Ao), pulmonal artery (PA), left atrium (LA) and left main coronary artery (LMCA). Doppler velocity waveforms from the LMCA were traced and
peak velocity and velocity time integrals were calculated during inhalation of 1.5% (B) and 3.5% (C) of isoflurane with oxygen.
doi:10.1371/journal.pone.0102147.g001
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calculated by the software. Angle correction was not used. CFR
was calculated as the ratio between coronary flow velocities
recorded at hyperemia (3.5% isoflurane) and at baseline (1.5%
isoflurane). CFRpeak was calculated as peak velocity at hyperemia/
peak velocity at baseline and CFRVTI was calculated as VTI at
hyperemia/VTI at baseline. Only echocardiographic examina-
tions performed by a single operator were included in each study
(Ang II-study: M.C.S., TAC-study: N.T.S.). After ultrasound,
blood pressure (BP) was measured invasively via a 2F microtip
pressure-volume catheter (SPR-838; Millar Instruments Inc,
Houston, TX, USA) in the ascending aorta [28,29].
Statistics
Data are reported as mean6standard error of the mean (SEM).
One way analysis of variance (ANOVA) was used to compare
groups and the Holm–Sidak method was used as post-hoc test.
Independent-Samples T-test was used to compare two groups.
Correlation between parametric variables was checked using
Pearson Correlation coefficient. A p-value of ,0.05 was consid-
ered statistically significant. PASW Statistics 18.0.3 (SPSS Inc.,
Chigaco, IL, USA) software was used for statistical analyses.
Results
In the Ang II-study we were able to obtain reliable Doppler flow
velocity waveforms from the LMCA in 28 (85%) of 33 animals that
had an echocardiography by the most experienced operator
(M.C.S.); 13 pregnant sham, 11 pregnant Ang II, 2 non-pregnant
sham, and 2 non-pregnant Ang II. Due to low numbers of non-
pregnant animals, only data from pregnant animals are presented
in Fig. 2. In the TAC-study echocardiography was performed by
one operator (N.T.S.) in all animals. LMCA flow velocity was
recorded in 36 of the 42 animals included. Four animals were
excluded due to poor signal quality or inability to repeat
measurements after increase of isoflurane concentration. Thus
CFR measurements from 32 (76%) animals were eligible for
analysis; 10 pregnant sham, 7 pregnant TAC, 7 non-pregnant
sham, and 8 non-pregnant TAC.
Ten male rats were used to evaluate the effect of inhaled
isoflurane on coronary flow. Coronary flow velocities increased
and stabilized one to two minutes after the concentration of
inhaled isoflurane was increased from 1.5% to 3.5%, and returned
to baseline values three to five minutes after the isoflurane
concentration was reduced to 1.5%. Increase in inhaled isoflurane
concentration above 3.5% in four rats did not lead to further
increase in coronary flow velocities, and there was no difference in
calculated CFRpeak or CFRVTI at 3.5% compared to 4.5% (two
rats) or 5.0%(two rats) concentration of inhaled isoflurane
(CFRpeak:1.7860.13 vs 1.6360.11, p = 0.4. CFRVTI: 1.9660.29
vs 2.0560.27, p = 0.3). In most animals measurement of coronary
flow was not feasible when the inhaled isoflurane concentration
was below 1.5% as the animals would start moving and the
coronary flow signals were lost. In two rats blood flow velocities
were similar at 1.0% and 1.5% isoflurane.
Adenosine infusion led to a significant increase in coronary flow
velocity only in one of four rats. In this rat the calculated CFRpeak
was similar following adenosine infusion and isoflurane inhalation
(1.82 and 1.89 respectively). In three rats not responding to
adenosine the calculated CFRpeak following isoflurane inhalation
was 1.11, 1.67 and 1.72.
Calculated CFRpeak and CFRVTI values are presented in Fig. 2.
There were no differences in CFRpeak or CFRVTI between
pregnant sham and pregnant AngII-infused rats. In the TAC-
study CFRpeak (1.5460.07 vs 1.8560.17, p = 0.03) but not
CFRVTI (1.5760.08 vs 1.7260.06, p = 0.3) was decreased in
pregnant compared to non-pregnant sham. TAC did not
significantly affect CFRpeak or CFRVTI in pregnant or non-
pregnant animals. When pregnant (n = 23) and non-pregnant
(n = 9) sham animals from both studies were pooled together and
compared, both CFRpeak (1.4260.07 vs 1.8660.16, p = 0.005,
Fig. 3) and CFRVTI (1.4560.07 vs 1.7860.12; p = 0.03) were
significantly decreased in pregnant animals. There was no
correlation between CFRpeak and systolic or diastolic BP, heart
weight or left ventricular contractility measured as left ventricular
fractional shortening by m-mode echocardiography.
Discussion
We measured CFR non-invasively in pregnant and non-
pregnant rats using high concentrations of inhaled isoflurane as
a vasodilating agent. We were able to calculate CFR using
Doppler flow velocity waveforms of LMCA in most animals. CFR
was reduced in pregnant rats compared to non-pregnant.
Furthermore, we investigated whether increased afterload has an
effect on CFR in pregnant and non-pregnant rats and found that
neither chronic Ang II infusion nor aorta constriction affected
CFR.
In the TAC-study CFRpeak was reduced in pregnant compared
to non-pregnant sham operated rats. The same trend was
observed in sham treated rats in the AngII-study (Fig. 2A),
however only two non-pregnant rats were examined and
difference was not statistically significant. Combining data on
sham animals from two studies, we found that both CFRpeak and
CFRVTI were significantly lower in pregnant compared to non-
pregnant rats. There are no published studies on CFR in
pregnancy. FMD reflects the endothelial function in the peripheral
resistance vessels but may not correlate with that of the coronary
vascular bed [17,25,26,30]. Studies in pregnant women have
shown that FMD decreases towards term [19,20,23] which is in
line with our findings.
To our knowledge, the effects of pregnancy on CFR have not
been studied before, and it is not known if reduced CFR increases
the risk of adverse cardiovascular events in pregnancy. A recent
study showed that the utero-placental blood flow is impaired in
pregnant women with congenital heart diseases [31].The course
and outcome of pregnancy may be affected by maternal heart
disease [32]. Death from heart disease is the leading cause of
indirect maternal death in the UK [33]. Hirata et al. have shown
an increase in CFR associated with increasing levels of 17b-
estrogen in the follicular phase of the menstrual cycle in young,
healthy women and after administration of conjugated estrogen in
postmenopausal women [34]. Profound hormonal changes that
occur during pregnancy could be responsible for reduced CFR
that we observed in rats close to term. There is a need for non-
invasive tests to asses risk and predict outcome in pregnant women
at risk. Thus, studies of CFR in healthy human pregnancies and in
pregnant women with hypertension or heart diseases using non-
invasive methods and safe vasodilating agents (e.g. dipyridamole, a
FDA category B drug) are warranted.
In contrast to previous findings in dogs [15] and mice [10] with
increased afterload, in our study CFR was not reduced by Ang II
infusion or TAC in rats. In addition to species differences, there
could be several other reasons for this discrepancy. Hittinger et al.
found that CFR was preserved in dogs with compensated heart
hypertrophy, but was exhausted when the dogs developed
decompensated pressure overload left ventricular hypertrophy
[15]. In our studies the animals did not have decompensated heart
failure when CFR was measured [28,29]. The coronary circula-
Coronary Flow Reserve in Pregnant Rats
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tion is subjected to autoregulation and coronary blood flow is
constant over a wide range of pressures, referred to as the ‘zero
pressure flow phenomenon’ [1,35]. When the vascular bed of the
heart is maximally vasodilated (e.g. by adenosine or isoflurane) the
coronary autoregulation is revoked and coronary blood flow
exhibits a linear relationship with the myocardial perfusion
pressure [1,36]. Therefore, a change in blood pressure will affect
CFR. As coronary flow is predominantly diastolic in the rat
LMCA (Fig. 1BC), an increase in diastolic BP may increase
calculated CFR. In our study, systolic rather than diastolic BP was
increased following TAC and the pregnant sham animals had a
significantly lower diastolic BP than all other groups [29].
Therefore, the reduced CFR in late pregnancy may be a result
of reduced diastolic BP rather than impaired coronary endothelial
function. Examining CFR and BP at mid-term could have added
valuable information, but we refrained from anaesthetising the
animals twice during pregnancy to avoid adverse effects on mother
and fetuses.
In contrary to TAC, chronic Ang II infusion led to significantly
increased diastolic as well as systolic pressure [28]. Furthermore,
Ang II infusion led to significant fibrosis of the heart tissue,
whereas TAC did not [28,29]. Thus the Ang II infused rats
probably were closer to heart failure. According to the ‘zero
pressure flow phenomenon’ an increased diastolic BP in Ang II
infused rats will increase calculated CFR and may mask an actual
impairment of the coronary vessels ability to dilate [1,35].
Hoffmann et al. defined CFR as the maximal increase in coronary
blood flow above its basal level for a given perfusion pressure when
coronary circulation is maximally dilated [37], and ideally
speaking, perfusion pressure needs to be taken into account while
comparing coronary flows in different animals. Thus, even though
the CFR was not significantly affected by Ang II infusion, we
cannot conclude that coronary microvascular dilatation is not
impaired by Ang II.
The gold standard method for measuring CFR is by using
adenosine infusion. We used inhaled isoflurane which is commonly
used as a safe anesthetic in rats. This method is non-invasive and
does not require insertion of an intravenous cannula and is more
practical. We found that this method of measuring CFR in rats
using different concentrations of inhaled isoflurane and echocar-
Figure 2. Coronary flow reserve in pregnant and non-pregnant rats. Mean 6SEM for coronary flow reserve calculated from peak velocities
(A, C) and velocity time integrals (B, D). Comparisons between groups were made using independent samples T-test (A, B) and one-way ANOVA and
Holm-Sidak post hoc test (C, D). SEM, standard error of the mean, NP, non-pregnant, Ang2, Angiotensin II, TAC, transverse aorta constriction, p,0.05
compared to non-pregnant sham (*).
doi:10.1371/journal.pone.0102147.g002
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diography is feasible in a laboratory setting. The operator of the
Ang II-study was more experienced in small-animal echocardiog-
raphy than the operator of the TAC-study and had a higher
success rate in obtaining reliable CFR measurements. However,
the difference between operators was not significant (p = 0.4). The
most frequent cause of not obtaining CFR measurements was
inability to detect LMCA flow velocity signals consistently. Using
an ultrasound system equipped with color Doppler could facilitate
the identification of coronary artery, and increase the success rate.
3.5% of isoflurane was chosen as high-concentration as this was
set as the maximum maintenance dose used in rats in our
laboratory. High concentrations of inhaled isoflurane may lead to
reduced cardiac output, reduced BP, circulatory collapse and
cardiac arrest. In four male rats an increase in isoflurane
concentration above 3.5% did not lead to further increase in
coronary flow velocity indicating that the coronary vessels were
maximally dilated at 3.5%.
Due to the small caliber of coronary artery and limited image
resolution, its diameter is difficult to measure and coronary volume
blood flow cannot be calculated non-invasively. However,
coronary flow reserve estimated using Doppler flow velocity
waveforms correlates well with invasively measured CFR [38].
Previous studies mostly report CFRpeak rather than CFRVTI. We
have presented both the CFRpeak and CFRVTI in our results.
An increase in peak velocity during the diastole is expected
following coronary vasodilatation. However, an increase in systolic
component was also observed during hyperemia (Fig. 1BC).
Therefore measuring VTI of the flow velocity waveform during
the whole cardiac cycle might be a better estimate of coronary flow
than just the peak velocity.
Conclusions
It is feasible to measure CFR in rats non-invasively using
Doppler echocardiography and high concentration of inhaled
isoflurane as the vasodilating agent. CFR was not affected by
increased left ventricular cardiac afterload caused by chronic Ang
II infusion or TAC both in pregnant and non-pregnant rats. CFR
is reduced in late pregnancy (close to term) in rats. Whether this
reduction is a result of impaired coronary endothelial function or is
merely a reflection of reduced diastolic BP in late pregnancy
remains to be elucidated.
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